RE-BVS – Piemonte Repository

Sfoglia per AUTORE
MUZI C
Collezione AOU Alessandria

Items : 3

Renoir phase III Rituximab-Lenalidomide vs Rituximab as Maintenance Treatment in Relapsed/Refractory Follicular Lymphoma. in Blood advances / Blood Adv. 2026 Jun 25:bloodadvances.2025018732. doi: 10.1182/bloodadvances.2025018732.

2026
AOU Alessandria

Botto B; Boccomini C; Evangelista A; Zilioli VR; Anastasia A; Cavallo F; Merli F; Zanni M; Tani M; Chiarenza A; Liberati AM; Conconi A; Rusconi C; Bari A; Del Giudice I; Gaidano G; Spina M; Maschio N; Castellino C; Rota-Scalabrini D; Puccini B; Arcari A; Bigliardi S; Matta GME; Bianchi B; Mannina D; Marino D; Galieni P; Ciambelli F; et alii...

Molecular biomarkers as key determinants of outcome in mantle cell lymphoma: results from the FIL V-RBAC trial. in Blood advances / Blood Adv. 2026 Jul 24:bloodadvances.2026020780. doi: 10.1182/bloodadvances.2026020780.

2026
AOU Alessandria

Moia R; Almasri M; Carazzolo ME; Cividini L; Tabanelli V; Melle F; Genuardi E; Cosentino C; Maher N; Bellia M; Mahmoud AM; Evangelista A; Quaglia FM; Fiori S; Bomben R; Tisi MC; Riva M; Merli A; Di Rotondo F; Corradini P; Farina L; Castellino C; Castellino A; Zilioli VR; Muzi C; Piazza F; Re A; Hohaus S; Rossi Dardanoni FG; et alii...

Rituximab, bendamustine, and cytarabine followed by venetoclax in older patients with high-risk mantle cell lymphoma (FIL_V-RBAC): a multicentre, single-arm, phase 2 study. in The Lancet. Haematology / Lancet Haematol. 2025 Oct;12(10):e777-e788. doi: 10.1016/S2352-3026(25)00252-2. Epub 2025 Sep 17.

2025
AOU Alessandria

Visco C; Tabanelli V; Sacchi MV; Evangelista A; Quaglia FM; Fiori S; Bomben R; Tisi MC; Riva M; Merli A; Rotondo F; Fraenza C; Carazzolo ME; Corradini P; Farina L; Castellino C; Castellino A; Zilioli VR; Muzi C; Piazza F; Re A; Hohaus S; Rossi FG; Musuraca G; Di Rocco A; Puccini B; Sciarra R; Ballerini F; Cavallo F; et alii...